Jh. Zhu et al., Cytomegalovirus in the pathogenesis of atherosclerosis - The role of inflammation as reflected by elevated C-reactive protein levels, J AM COL C, 34(6), 1999, pp. 1738-1743
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES We hypothesized that cytomegalovirus ( infection: 1) stimulates
an inflammatory response, reflected by elevated C-reactive protein (CRP) le
vels, and 2) predisposes to coronary artery disease (CAD), in part, through
CMV-induced inflammation.
BACKGROUND Although some studies show an association between CMV and athero
sclerosis, others do not. We believed that CMV exerted an atherogenic effec
t by inducing inflammation, and the disparate results may derive partly fro
m individual variability in the capacity to control CMV inflammatory activi
ty.
METHODS Blood samples were tested for CMV seropositivity and CRP levels fro
m 238 individuals being evaluated for CAD by coronary angiography.
RESULTS An elevated CRP level (>0.5 mg/dl) was a significant CAD determinan
t even after adjustment for traditional CAD risk factors (odds ratio [OR] =
2.4; p = 0.02). Moreover, CMV seropositivity was significantly associated
with increased CRP levels ip = 0.04 after adjustment for CAD risk factors),
suggesting that CMV could evoke subclinical inflammatory response. However
, considerable host variation existed in this response to CMV. When adjuste
d for CAD risk factors, the OR for CAD were 1.3 in the subgroup with CMV se
ropositivity alone (p = 0.7), 2.3 in the subgroup with elevated CRP levels
alone (p = 0.2), and 4.3 in the subgroup with combined CMV seropositivity a
nd elevated CRP levels (p = 0.01).
CONCLUSIONS Our results suggest that 1) CMV elicits a subclinical inflammat
ory response, but only in certain individuals, and 2) individuals with an i
nflammatory response appear susceptible to the atherogenic effects of CMV w
hereas those without appear resistant. These results may partly explain the
disparate results of studies attempting to relate CMV to atherogenesis. (C
) 1999 by the American College of Cardiology.